Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_226_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
13.10.2026
Размер:
2 Мб
Скачать
☆
121
171. Vernon, G. Systematic review: the epidemiology and natural history of

A. Baranova, Z. M. Younossi // Alimentary pharmacology & therapeutics. 2011.
 P. 274285.
172. Williams, R. Global challenges in liver disease / R. Williams // Hepatology.
2006.  P. 521526.
173. Wyatt, J. Tissue pathways for liver biopsies for the investigation of medical
disease and for focal lesions / 
of Pathologists. London, 2014. 29 p.
174. Younossi, Z. Contribution of alcoholic and nonalcoholic fatty liver disease
to the burden of liver-related morbidity and mortality / Z. Younossi, L. Henry //
Gastroenterology. 2016.  P. 17781785.
https://t.me/med1917
122
 .

          
         
         

https://t.me/med1917
123
.


49/06 (2006         
 
https://t.me/med1917
124


CUM10




F1-2
F3-4

CUM_10>1%
18(33,96%)
28(52,83%)
7(13,2%)
53(100%)
CUM_10< 1%
8(16,67%)
18(37,5%)
22(45,83%)
48(100%)
CUM_10 
26(25,74%)
46(45,55%)
29(28,71%)
101(100%)
OR) =2,580882
 
13
-

https://t.me/med1917
125


CUM20



F0-1-2
F3-4

CUM20>2,5%
59(84,29%)
11(15,71%)
70(100%)
CUM20< 2,5%
13(41,94%)
18(58,06%)
31(100%)

72(71,29%)
29(28,71%)
101(100%)
OR)= 6,895105
        
13
-
        

https://t.me/med1917
126


CUM30



F0
F1
F2
F3
F4

CUM30>5,65%
20
(30,76%)
19
(29,23%)
18
(27,69%)
6
(9,23%)
2
(3,07%)
65
(100%)
CUM30<5,65%
6
(16,67%)
4
(11,11%)
5
(13,89%)
6
(16,67%)
15
(41,67%)
36
(100%)


26
(25,74%)
23
(22,77%)
23
(22,77%)
12
(11,88%)
17
(16,83%)
101
(100%)
OR)=23,33333
        
13
-
5,6 
https://t.me/med1917